|
HY-10209A-5mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-10209A-50mg
|
MedChemexpress LLC
|
Masitinib (mesylate) [CAS 1048007-93-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-103177-10mg
|
MedChemexpress LLC
|
PSB-10 (hydrochloride) [CAS 591771-91-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103177-5mg
|
MedChemexpress LLC
|
PSB-10 (hydrochloride) [CAS 591771-91-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103387-1mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103387-10mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-103387-5mg
|
MedChemexpress LLC
|
DuP-697 [CAS 88149-94-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-106934-10mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-100mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-5mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934-50mg
|
MedChemexpress LLC
|
Peldesine [CAS 133432-71-0]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-10mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-100mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-5mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-106934A-50mg
|
MedChemexpress LLC
|
Peldesine (dihydrochloride) [CAS 2772702-10-8]
|
|
COVID-19-anti-virus
|
|
|
HY-107615-10mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-107615-100mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-107615-25mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-107615-5mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-107615-50mg
|
MedChemexpress LLC
|
TC LPA5 4 [CAS 1393814-38-4]
|
|
Cancer-programmed cell death
|
|
|
HY-124569-10mg
|
MedChemexpress LLC
|
NAB-14 [CAS 1237541-73-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-124569-100mg
|
MedChemexpress LLC
|
NAB-14 [CAS 1237541-73-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-124569-25mg
|
MedChemexpress LLC
|
NAB-14 [CAS 1237541-73-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-124569-5mg
|
MedChemexpress LLC
|
NAB-14 [CAS 1237541-73-9]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-124569-50mg
|
MedChemexpress LLC
|
NAB-14 [CAS 1237541-73-9]
|
|
Neuroscience-Neurodegeneration
|
|
